HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

503.398

-20.475-3.91%

Number of Gainers:8

Number of Losers:24

Number of Flat:1

PE:- -

High:523.582

Open:523.582

Low:498.297

Close:523.873

Volume:119.87M

Turnover:3.20B

Market Cap:322.68B

Float Cap:286.07B

Loading ...

Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces

Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating

AI-Driven Drug Discovery Reshaping Scientific Research Paradigms, Long-Term Focus on Continuously Evolving R&D Platforms

When Will CStone Pharmaceuticals (HKG:2616) Breakeven?

Simply Wall St.

Unpacking ALEBUND-B's First Half Results: The Compounding Growth Logic of a Kidney Disease-Focused Biopharma

InnoCare Pharma Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption

Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens

Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO

MP CARDIOFLOW-B Announces New Leadership Appointments

MicroPort CardioFlow Delays Board Meeting on Interim Results Release

MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles

Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President

THOMSON REUTERS

Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman

THOMSON REUTERS

MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian

BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss Narrowing 50.8% to RMB 26.596 Million

ACFTU Launches Second National Team Leader Competition With Ten Industry Tracks Including Rail, Power, Pharma, Machinery, Metallurgy, Building Materials, Defense Tech, ICT, Light Industry, and Textiles

China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1574/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":503.39795,"timestamp":1788163726135,"preClose":523.8731,"halted":0,"volume":119868273,"delay":0,"changeRate":-0.039084,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-20.475159,"latestTime":"08-31 16:00:00","open":523.582,"high":523.582,"low":498.29733,"amount":3203299214.5,"amplitude":0.048265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":3.790203,"peRate":127.340212,"turnoverRate":0.003654,"increases":8,"decrements":24,"flats":1,"marketCap":322680201168,"floatMarketCap":286067329608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":523.582,"amplitude":0.048265,"preClose":523.8731,"low":498.29733,"pbRate":"3.790203","latestPrice":503.39795,"volume":119868273,"delay":0,"open":523.582,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.742,"twentyDayClose":467.18,"sixtyDayClose":475.465,"secType":"PLATE","market":"HK","turnoverRate":0.003654,"peRate":127.340212,"marketCap":322680201168,"floatMarketCap":286067329608,"timestamp":1788163726135,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":8,"down":24,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153198003","title":"Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces","url":"https://stock-news.laohu8.com/highlight/detail?id=1153198003","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153198003?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:30","pubTimestamp":1787801432,"startTime":"0","endTime":"0","summary":"As interim earnings reports flood the market, the innovative drug sector has reignited investor enthusiasm, with several leading stocks surging post-results. On August 26, Innovent Biologics jumped...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159316","520880","159992","LNGR","FLHK","BK1574","06978","BK1161","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185413400","title":"Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1185413400","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185413400?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:01","pubTimestamp":1787799711,"startTime":"0","endTime":"0","summary":"Akeso (09926) climbed more than 6% during Wednesday's trading session before paring gains, last up 2.34% at HK$96.40 with turnover reaching HK$686 million.On August 26, Akeso announced that its phase...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","LU0348767384.USD","LU0417516902.SGD","KURE","LU0348735423.USD","LU0634319403.HKD","LU0417516738.SGD","002736","LU0348766576.USD","LU0540923850.HKD","BK1574","LU2488822045.USD","BK0188","LU1794554557.SGD","BK0028","LU2778985437.USD","BK0183","IE00BPRC5H50.USD","BK1161","LU0348783233.USD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0417516571.SGD","LU2399975544.HKD","LU1720050803.USD","LU1961090484.USD","LU0348825331.USD","LU0348827113.USD","LU0348784397.USD","LU0561508036.HKD","LU2476274720.SGD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134623279","title":"AI-Driven Drug Discovery Reshaping Scientific Research Paradigms, Long-Term Focus on Continuously Evolving R&D Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=1134623279","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134623279?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:04","pubTimestamp":1787796269,"startTime":"0","endTime":"0","summary":"Zheshang Securities has released a research report indicating that the pharmaceutical R&D industry is undergoing a similar industrial transformation: the number of biochemical large models is growing...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","ARTY","BK1191","AIPO","BK0276","AGIX","QTOC","BK1574","01477","CHAT","601878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720848","title":"When Will CStone Pharmaceuticals (HKG:2616) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720848","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720848?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:24","pubTimestamp":1787793884,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at CStone Pharmaceuticals...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/when-will-cstone-pharmaceuticals-hkg2616-breakeven-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/when-will-cstone-pharmaceuticals-hkg2616-breakeven-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135812657","title":"Unpacking ALEBUND-B's First Half Results: The Compounding Growth Logic of a Kidney Disease-Focused Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1135812657","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135812657?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:04","pubTimestamp":1787789077,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) delivered its inaugural interim results on August 26, marking a significant milestone since its listing, with revenue scaling to 8.6 times the figure reported in the same period...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","159938","09637","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662725758","title":"InnoCare Pharma Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662725758","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662725758?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:21","pubTimestamp":1787782887,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited ( HKG:9969 ) last week reported its latest half-year results, which makes it a good time for...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-beat-analyst-estimates-see-what-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-beat-analyst-estimates-see-what-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","PMDE","RGLO","FEBU","BK1574","09969","GXDW","BK1161","DECU","VGFPF","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163553180","title":"Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption","url":"https://stock-news.laohu8.com/highlight/detail?id=1163553180","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163553180?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:30","pubTimestamp":1787758250,"startTime":"0","endTime":"0","summary":"Boston Scientific disclosed in a Wednesday filing with the U.S. Securities and Exchange Commission (SEC) that it has been struck by a cyberattack, impacting its business operations. The incident is...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU2491050071.SGD","LU0011850046.USD","LU2506951958.HKD","LU2491050154.USD","SPAM","LU1989772923.USD","SG9999001176.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0187121727.USD","LU1718418525.SGD","SGXZ57979304.SGD","UCYB","BK4585","HAKY","LU0138981039.USD","LU1989764664.SGD","MDEV","LGHT","BK1574","LU1057294990.SGD","LU0528227936.USD","LU0882574055.USD","IE0009355771.USD","LU2357305700.SGD","LU0823417737.USD","LU0823417653.USD","LU1548497426.USD","LU1720051017.SGD","HART","SG9999001176.USD","IE00B4R5TH58.HKD","LU0077335932.USD","LU0345769128.USD","LNGR","LU1804176565.USD","BK4581","RSPH","BK1583","WCBR","LU2244417387.USD","LU2506952097.USD","LU0266013472.USD","LU2242649171.HKD","IE00B2B36J28.USD","LU1791710400.SGD","LU1061106388.HKD","LU2491049909.HKD","PTH","LU0238689110.USD","BK4588","LU2506951875.HKD","LU1989764748.USD","LU0122379950.USD","LU2506952170.USD","LU1720051108.HKD","LU1791710582.SGD","LU0353189680.USD","09996","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0267386448.USD","LU2265009873.SGD","LU2362540622.SGD","LU0225283273.USD","LU2324357040.USD","BSX","SG9999013999.USD","LU1989771016.USD","LU0048584097.USD","BK1100","IEIH","BK4082","LU2362541273.HKD","LU0950375773.USD","LU0114720955.EUR","LU1153585028.USD","AGNG","LU0353189763.USD","IE00BJJMRZ35.SGD","LU2087625088.SGD","GDOC","LU0823416689.USD","LU1983299246.USD","LU0432979614.USD","MEDX","LU0345769631.USD","LU1291159041.SGD","LU1366192091.USD","LU2112291526.USD","159883","LU0251132253.USD","LU1989772840.SGD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125221751","title":"Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens","url":"https://stock-news.laohu8.com/highlight/detail?id=1125221751","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125221751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:20","pubTimestamp":1787757649,"startTime":"0","endTime":"0","summary":"The innovative drug industry is defined by its \"double ten\" characteristics—a research and development cycle of roughly a decade and an investment of about one billion US dollars per molecule. During...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","159992","LNGR","BK1574","DCF","BK1161","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662106748","title":"Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662106748","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662106748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:08","pubTimestamp":1787756895,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned As CEOAug 26 -Microport Cardioflow Medtech Corp2160.HK:ZHANG RUINIAN HAS RESIGNED AS CHIEF EXECUTIVE OFFICER, APPOINTED AS PRESIDENTCHEN GUOMING RESIGNED AS CHAIRMAN, RE-DESIGNATED TO EXECUTIVE DIRECTOR, APPOINTED AS CEOBRIAN CHANG HAS BEEN APPOINTED AS CHAIRMANFurther company coverage:2160.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02160","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128341122","title":"MP CARDIOFLOW-B Announces New Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1128341122","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128341122?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:02","pubTimestamp":1787756533,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1225","02918","BK1100","BK1574","BK1239","BK1583","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573748","title":"MicroPort CardioFlow Delays Board Meeting on Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756331,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow delays board meeting on interim results releaseMicroPort CardioFlow Medtech rescheduled its board meeting to Aug. 31, 2026, from Aug. 26, 2026.Session will review interim results ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL6mSG1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1574","BK1100","02160","BK1585","00853","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574857","title":"MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662574857?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756324,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow files board and committee member list with disclosure rolesMicroPort CardioFlow Medtech (2160) updated its board and committee lineup in a filing dated Aug. 26, 2026.Brian Chang l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7XTd8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1583","BK1589","02160","00853","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748578","title":"Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748578?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1583","BK1574","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662485717","title":"Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2662485717","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662485717?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1574","BK1583","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748576","title":"MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748576","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748576?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756289,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang RuinianMicroPort CardioFlow Medtech named Guoming Chen chief executive, replacing Ruinian Zhang, effective Aug. 26, 2026.Chen stepped down ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLb6bRcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","02160","BK1589","BK1574","BK1583","BK1100","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120341827","title":"BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss Narrowing 50.8% to RMB 26.596 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120341827","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120341827?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:52","pubTimestamp":1787755941,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) has announced its interim results for 2026, recording revenue of RMB 36.635 million, a year-on-year increase of 147.8%. Gross profit reached RMB 34.08 million, up 147.9%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02563","BK1515","09939","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187289311","title":"ACFTU Launches Second National Team Leader Competition With Ten Industry Tracks Including Rail, Power, Pharma, Machinery, Metallurgy, Building Materials, Defense Tech, ICT, Light Industry, and Textiles","url":"https://stock-news.laohu8.com/highlight/detail?id=1187289311","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187289311?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:11","pubTimestamp":1787753476,"startTime":"0","endTime":"0","summary":"The All-China Federation of Trade Unions (ACFTU) General Office has issued a notice to fully launch the second National Team Leader Competition, aiming to strengthen enterprise team building, better...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLTA","DRNL","BK1161","BK1574","LOUP","PLTI","PTIR","ROKT","CRTC","AMMO","PLTU","JEDI","THMZ","159146","PLOO","PLTY","WAR","PLYY","PLTG","PLTD","09939","USMD","159938","PLTW","FITE","BTHM","XDEF","BK1515","PLTZ","PLTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142229559","title":"China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229559","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229559?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:10","pubTimestamp":1787753427,"startTime":"0","endTime":"0","summary":"BeiGene Ltd (SH: 688235), trading at 279.00 yuan per share with a market capitalization of 430.298 billion yuan, released its semi-annual report for 2026 on August 26. The report reveals that the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06978","BK1574","LNGR","BK1161","IBBQ","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184470015","title":"Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve","url":"https://stock-news.laohu8.com/highlight/detail?id=1184470015","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184470015?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:28","pubTimestamp":1787750895,"startTime":"0","endTime":"0","summary":"Lee's Pharmaceutical Holdings Ltd (00950) has issued a positive profit alert, indicating that the group expects to report an audited net profit attributable to shareholders of between approximately...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06622","BK1191","BK1574","BK1583","00950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662160207","title":"CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2662160207","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662160207?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:08","pubTimestamp":1787746092,"startTime":"0","endTime":"0","summary":"CanSino Biologics'  subsidiary CanSino  Biological Research entered into a strategic cooperation framework agreement with deepGeneAI to jointly develop personalized mRNA therapeutic cancer vaccines.The companies will explore combining CanSino's mRNA vaccine technology with deepGeneAI's tumor neoantigen discovery and design capabilities, according to a Wednesday Hong Kong bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","ADC","BK1574","BK1515","BK1191","06185","NETL","BK4080","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":7,"totalSize":380,"code":"91000000","status":"200"}]}}